Shah Preetam

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$76,729.04
Insider Sells Quantity
3
Insider Sells Sum
$34,886.37

Insider Activity of Shah Preetam

According to the SEC Form 4 filings, Shah Preetam, being in a position of

  1. CFO & CBO at Cidara Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 18931 share for $12,680,
    over all time since 2021-11-12, has bought 20000 shares for $30,800, and sold 41221 share for $34,886.

The largest purchase of all time was on 2019-12-24 and amounted to 11600 shares of Brainstorm Cell Therapeutics Inc. for $45,929.

The largest sale of all time was on 2024-03-11 and amounted to 18931 share of Cidara Therapeutics, Inc. for $12,680.

Biography of Shah Preetam

No biography is available at this moment.

2024-03-11SaleCidara Therapeutics, Inc.
CDTX
CFO & CBO
18,931
0.0212%
$0.67$12,680-4.43%
2023-03-13SaleCidara Therapeutics, Inc.
CDTX
CFO & CBO
6,648
0.0075%
$1.53$10,171-45.66%
2022-09-19SaleCidara Therapeutics, Inc.
CDTX
CFO & CBO
15,642
0.0226%
$0.77$12,035+38.16%
2021-11-12PurchaseCidara Therapeutics, Inc.
CDTX
CFO & CBO
20,000
0.0365%
$1.54$30,800-55.28%
2019-12-24PurchaseBrainstorm Cell Therapeutics Inc.
BCLI
EVP, CFO and Treasurer
11,600
0.0409%
$3.96$45,929+85.06%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.